Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2035

Annual patent cliff calendar for 2035 — US pharmaceutical patents by expiration date.

Patents
1,447

Quick answer

1,447 indexed pharmaceutical patents have expiration dates in 2035. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8927249

    Extended soluble PH20 polypeptides and uses thereof

    HALOZYME, INC. · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8927233

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8927269

    Avian adenoassociated virus and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8926986

    Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8927692

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Inovio Pharmaceuticals, Inc. · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8927718

    Fused heterocyclic ring derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8926969

    Anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8927573

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8927495

    Use of GnRH and analogs thereof for the prevention and treatment of pet ferret adrenocortical hyperplasia

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8926987

    Replication-competent adenoviral vectors

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8927750

    Acyloxy- and phosphoryloxy-butadiene-Fe(CO)3 complexes as enzyme-triggered co-releasing molecules

    UNIVERSITAET REGENSBURG · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8927730

    Intramolecular hydrogen-bonded nitric oxide synthase inhibitors

    Northwestern University · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8927215

    GNA11 mutations in melanoma

    The Regents of the University of California · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8927709

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8927030

    Use of nitrite salts for the treatment of cardiovascular conditions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8927275

    Differentiation of human embryonic and induced pluripotent stem cells

    UNIVERSITY OF CONNECTICUT · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8927725

    Thio compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8926965

    Nucleic acid encoding superoxide dismutase variants and methods of use thereof

    The Regents of the University of California · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8927506

    Acetates of 2-deoxy monosaccharides with anticancer activity

    The Board of Regents of the University of Texas System · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8927557

    Methylpyrrolopyrimidinecarboxamides

    TAKEDA GMBH · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8926966

    Cloned glutamic acid decarboxylase

    The Regents of the University of California · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8927528

    Composition for treating hearing loss

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8927576

    HCV inhibitor and therapeutic agent combinations

    PTC THERAPEUTICS, INC. · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8927016

    Producing a sustained-release preparation

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8927564

    Synthesis of polycyclic alkaloids

    Rigel Pharmaceuticals, Inc. · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. EP 2819679

    FLÜSSIGE FORMULIERUNGEN ENTHALTEND HYPOGLYZEMISCHE SULFAMIDE

    AMMTEK [FR] · Granted Wed Jan 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jan 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8932846

    Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins

    The Regents of the University of California · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8933030

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8933203

    Vault and vault-like carrier molecules

    The Regents of the University of California · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8933110

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8932583

    Scaffolds for cell transplantation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8932060

    Dental treatment method

    KURARAY NORITAKE DENTAL INC. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8933071

    Dimethyl fasudil for inducing polyploidization of megakaryocytes and for treating blood and bone marrow diseases and disorders

    Northwestern University · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8933031

    Polypeptide inhibiting angiogenesis and application thereof

    SHANGHAI FIRST PEOPLE'S HOSPITAL · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8933080

    Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8933047

    Poly(acrylate) polymers for in vivo nucleic acid delivery

    Arrowhead Madison, Inc. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8933069

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8932561

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Lutonix, Inc. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8932572

    Poly(vinyl ester) polymers for in vivo nucleic acid delivery

    Arrowhead Madison, Inc. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8932853

    Method for manufacturing pancreatic-hormone-producing cells

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8932818

    Screening assays for compounds that modulate programmed ribosomal frameshifting

    PTC THERAPEUTICS, INC. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8932588

    Treatment of cancer involving mutated KRAS or BRAF genes

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8933041

    System for treating and preventing breast cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8933059

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8933105

    Pyrrole compounds

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8933115

    Stabilized statin formulations

    Cumberland Pharmaceuticals Inc. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8933076

    Pyridazine compounds, compositions and methods

    Northwestern University · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8933111

    Crystalline form of (2S,4R)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1H-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester

    Theravance Biopharma R&D IP, LLC · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2035?

1,447 published patents in our USPTO index have expiration dates falling in calendar year 2035.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.